From Sports Performance to Healthy Aging, Creatine Finds New Momentum

There have been a multitude of misconceptions surrounding creatine that have been heard time and time again: Creatine can cause weight gain. It’s just for athletes.

These couldn’t be further from the truth,¹ especially the latter. In reality, the ingredient is continuing to gain traction among standard gym goers trying to build muscle for competition, and its popularity is growing among broader active nutrition consumers as well.

Now, a shift focused on optimizing cellular energy is underway, and manufacturers are continually moving toward more clinically validated solutions, not just in sports nutrition, but also in brain health, metabolic resilience, and healthy aging.

Creatine’s Reputation Evolves Beyond Muscle Building

Creatine monohydrate’s (CM) positive reputation—made apparent by the various options² at suppliers’ fingertips—certainly doesn’t come without having the proper scientific proof³ to back it up.

However, experts in the nutraceuticals space, such as Lauren Clardy, Maypro’s senior director of scientific affairs, have argued that while traditional CM is well-studied and effective, it’s not without limitations. For example, it must first be converted within muscle cells before the body can fully utilize it, presenting some limitations related to absorption and tolerability.

For that reason, molecular complexes such as Clonapure aim to enhance creatine absorption and utilization, potentially supporting more consistent performance outcomes while providing added versatility for product formulation.

“Clonapure leverages a more advanced composition to enhance the phosphagen energy system directly, which translates into improved ATP availability, faster uptake, and more efficient energy utilization. From a formulation standpoint, this also provides greater flexibility for innovation across delivery formats and use cases beyond traditional sports powders,” Clardy noted.

CM can also be challenging to formulate with given the potential for sedimentation and gritty mouthfeel, though innovation continues as suppliers and formulators find ways to improve the sensory experience.

Cellular Energy Metabolism Drives New Research Directions

ATP, otherwise known as adenosine triphosphate, is known as the brain’s main currency for energy. When the brain is unable to efficiently produce or recycle ATP, communication between brain cells may become less coordinated, impacting cognition, memory, mood, and overall brain performance. There is also ongoing scientific interest in mitochondrial health and cellular energy metabolism⁴ as vital factors that affect brain health and neurological function.

In other words, ATP needs to be constantly replenished to be effective, which is necessary in any sort of physical activity.

This growing interest in cellular energy metabolism has expanded around creatine’s potential role beyond exercise performance. Researchers are increasingly examining how creatine may support brain energy production and neurological resilience.

“Currently, the most well-established benefits of creatine outside of muscle performance are the benefits being demonstrated in brain health,” said Mark Faulkner, founder and CEO of Vireo Systems, the manufacturer of CON-CRĒT Creatine. “Either high doses of CM (15-20 g) or lower doses of creatine hydrochloride (750 mg to 1.5 g, or also up to 6 g for serious neurodegenerative conditions) are showing effective increases in brain energy metabolism coming from increased brain creatine levels.”

Research suggests increased energy availability may help neurons function more efficiently and remain more resilient during conditions such as disease or extreme fatigue, with additional studies underway showing promising early findings in traumatic brain injury and concussion support.

Combination Formats Bring Added Functional Benefits

An ingredient that often goes hand-in-hand with creatine is magnesium (in the form of magnesium citrate and magnesium phosphate). Balchem produces and markets Creatine MagnaPower, a compound combining creatine and magnesium in these 2 forms to take advantage of the synergistic benefits.

“Thanks to this connection, Creatine MagnaPower delivers muscular performance benefits (including improvements in cellular hydration, anabolic signaling, muscle power and torque) beyond what is achievable when taking creatine monohydrate and magnesium separately,”⁵ said Oliver Riemann, senior manager of marketing and business development, Albion Minerals, Balchem Human Nutrition & Health. “The magnesium citrate component in particular supports this by being efficiently absorbed into the muscles,⁶ ensuring magnesium is available where it is needed most. In practice, this translates to performance gains, with placebocontrolled clinical studies showing significantly reduced sprint times in elite football players,⁷ and increased bench press work capacity in gym goers.”⁸

Delivery Innovation Targets Everyday Wellness Consumers

The transition of creatine from a specialized sports supplement to a daily wellness staple requires a corresponding evolution in delivery formats.

According to Shawn Baier, senior director of global ingredient science with TSI Group, which produces OptiCreatine, the industry's focus is shifting toward enjoyable, consumer-friendly technologies that bridge the gap between lab-proven efficacy and real-world adherence.

“Looking ahead, innovation won’t just center in on discovering ‘new’ creatine benefits,” he explained. “It will also be focused on delivering existing benefits in ways consumers can actually maintain long term. …That’s why TSI has invested so heavily in enjoyable, consumer‑friendly delivery formats. This includes technologies like fast‑melt powders, chewables, stable gummies, and clear effervescent beverages. These formats remove the traditional friction associated with daily creatine use.”

Creatine’s Emerging Role in GLP-1 Support and Healthy Aging

Alongside its more well-known benefits, creatine’s connection to GLP-1-associated muscle and cognitive preservation associated with glucagon-like peptide-1 (GLP-1) have also been documented.

Of course, GLP-1 receptor agonists are primarily popular in the pharma sector, but the ingredient is starting to be used hand-in-hand by individuals who are on GLP-1 therapies. A narrative review⁹ concluded that when used as an adjunct, protein supplements—specifically CM and HMB (beta-hydroxy beta-methylbutyrate)—could help users meet their increased protein needs and preserve lean muscle mass during weight loss, especially when combined with resistance training.

There is also a growing overlap between active nutrition and healthy aging that is reshaping how creatine is being positioned to consumers. Rather than focusing solely on sports performance, ingredient manufacturers are increasingly emphasizing the ingredient’s potential role in supporting strength, mobility, and muscle preservation across different life stages.

“As creatine adoption expands beyond athletes, communication naturally shifts toward life-stage relevance—educating on how it supports strength, muscle preservation, and functional performance, especially in women and older adults,” Baier said. “Research increasingly supports creatine’s role in maintaining lean mass and physical function when paired with resistance training, which resonates strongly with active-aging and longevity-focused consumers.”

Closing Thoughts

As research into creatine continues to grow, the ingredient is increasingly being positioned as more than a pillar of sports nutrition. Emerging science surrounding brain energy metabolism, cellular resilience, healthy aging, and muscle preservation is helping reshape consumer perception and product innovation alike.

At the same time, advancements in delivery systems and synergistic formulations allow manufacturers to tackle long-standing concerns around texture, absorption, and usability. With growing clinical interest and broader consumer adoption, creatine appears poised to play a larger role in the future of active and everyday wellness nutrition.

References

1. Woodhurst, J. 5 common creatine myths busted. Ancient + Brave. Accessed May 13, 2026. https://ancientandbrave.earth/blogs/news/creatine-5-common-myths-busted?srsltid=AfmBOor95z4tpLGR1O8LGQ77I4kwuKY3uRV0-nQlvAJFWgw9cl-RoxbM 
2. Qura Creatine. Challenger brand set to redefine premium creatine monohydrate category. Prezly. March 25, 2026. Accessed May 13, 2026. https://qura-creatine.prezly.com/challenger-brand-set-to-redefine-premium-creatine-monohydrate-category?utm_source=prezly.com&utm_medium=campaign&utm_campaign=PRESS+RELEASE%3A+Challenger+brand+set+to+redefine+premium+creatine+monohydrate+category&utm_id=64e5600a-d3be-4319-96ea-f285a5af445d&utm_content=story+title 
3. Xu C, Bi S, Zhang W, Luo L. The effects of creatine supplementation on cognitive function in adults: a systematic review and meta-analysis. Front Nutr. 2024;11:1424972. doi:10.3389/fnut.2024.1424972 
4. Song X. Energy metabolism and brain functions. Harvard Brain Science Initiative. Accessed May 13, 2026. https://brain.harvard.edu/hbi_news/energy-metabolism-and-brain-functions/ 
5. Brilla LR, Giroux MS, Taylor A, Knutzen KM. Magnesium-creatine supplementation effects on body water. Metabolism. 2003;52(9):1136-1140. doi:10.1016/s0026-0495(03)00188-4 
6. Ates M, Kizildag S, Yuksel O, et al. Dose-dependent absorption profile of different magnesium compounds. Biol Trace Elem Res. 2019;192(2):244-251. doi:10.1007/s12011-019-01663-0 
7. Zajac A, Golas A, Chycki J, Halz M, Michalczyk MM. The effects of long-term magnesium creatine chelate supplementation on repeated sprint ability (RAST) in elite soccer players. Nutrients. 2020;12(10):2961. doi:10.3390/nu12102961 
8. Selsby JT, DiSilvestro RA, Devor ST. Mg2+-creatine chelate and a low-dose creatine supplementation regimen improve exercise performance. J Strength Cond Res. 2004;18(2):311-315. doi: 10.1519/R-13072.1 
9. Johnson BVB, Milstead M, Kreider R, Jones R. Dietary supplement considerations during glucagon-like peptide-1 receptor agonist treatment: a narrative review. Obes Pillars. 2025;16:100209. doi:10.1016/j.obpill.2025.100209